Global Market Data
Tales from the Trail
Lucy P. Marcus
David Cay Johnston
The Great Debate
Macro & Markets
Personal Finance Video
Life & Culture
Romney cements front-runner status
Worst ahead for euro zone: Reuters poll
Assad vows victory, Syria accused of war crimes
Hostess returns to bankruptcy over pensions
Iran blames Israel for killing nuclear scientist
Dell plots late-2012 consumer tablet launch
Growing wealth divide puts globalization at risk
Hastings: Obama’s power grab at the Pentagon
Slideshow: Fuel protests in Nigeria
Video: Korean troops: cold as ice
U.S. military moves carriers, denies Iran link
11 Jan 2012
Anthony says she became pregnant after passing out at party
11 Jan 2012
Buffett to Republicans: if you pay, so will I
11 Jan 2012
WRAPUP 2-Bomb kills Iran nuclear scientist as crisis mounts
11 Jan 2012
Marine abuse tape may dent Afghan peace talk drive
Huntsman outraged at ad targeting adopted daughters
Buffett to GOP: You pay and so will I
Gay marriage a threat to humanity’s future-Pope
U.S. Marines probe video of men urinating on Taliban corpses
Wed, Jan 11 2012
TV makers battle at CES
Wed, Jan 11 2012
Bungee jumper plummets into Zimbabwe river
Sun, Jan 8 2012
Samsung may consider alliance with Olympus: source
Samsung open to "alliance" with Olympus: source
Analysis & Opinion
Private equity skewered by Romney-bound arrows
Tech wrap: Nokia throne in Samsung’s sights
Global Deals Review: 2011 Q3 »
Global Deals Review: 2011 Q2 »
Global Deals Review »
Inflows Outflows »
South Korea »
Consumer Electronics Show »
The logo of Olympus is seen behind traffic signs outside an electronic shop in Tokyo December 5, 2011.
Credit: Reuters/Kim Kyung-Hoon
By Hyunjoo Jin and Emi Emoto
Thu Jan 12, 2012 2:42am EST
SEOUL/TOKYO (Reuters) - South Korea's Samsung Electronics is open to forging an alliance with Japan's troubled Olympus Corp, potentially joining other electronics firms in circling one of the world's biggest names in medical equipment, sources said.
Samsung's major Japanese rivals, Sony and Panasonic, have already shown interest in Olympus, now in need of capital after being swamped by a $1.7 billion accounting scandal over the past three months, sources in Tokyo have told Reuters.
Olympus is best known for cameras, but makes most of its money in healthcare, dominating the market for gastro-intestinal endoscopes which are seen as the kind of high-tech, profitable and stable business that electronics firms would covet.
Samsung has ruled out any interest in Olympus' loss-making camera business, but a company source said on Thursday that it might consider an alliance with Olympus in other areas.
"We are open to the possibility of an alliance with Olympus," the source with knowledge of the matter said on condition of anonymity, without elaborating.
Earlier, the Asahi Shimbun newspaper reported that Olympus was scouting out the electronics industry for a friendly investor to take a minority stake in the company, and that Olympus had drawn up a short-list of five potential partners.
The daily, quoting unnamed sources, listed them as Samsung, Sony, Panasonic, Japanese medical-equipment firm Terumo Corp, which already has a small stake in Olympus, and endoscope rival Fujifilm Holdings.
Olympus turned almost overnight from a venerable blue chip to an investor's nightmare in October, when it fired its British chief executive, Michael Woodford, who then went public with his concerns about the firm's dubious book-keeping.
It has since lost about 40 percent of its share price - though it has recovered from an 80 percent sell-off at one stage - and its management is in disgrace after the firm was found to have hidden losses from investors for 13 years.
Its plight is a potential opportunity for the electronics industry, which has been pushing into healthcare.
A Samsung Electronics spokeswoman said on Thursday it had not received a detailed offer from Olympus regarding a tie-up.
Samsung has targeted healthcare for growth as it diversifies away from businesses where it commands leading positions such as electric components, mobile phones and TVs. It has said it will aggressively pursue investments and acquisitions in new areas such as healthcare and renewable energy.
In November, it bought U.S. cardiac-testing firm Nexus, its second healthcare acquisition last year.
OLYMPUS LOOKS TO RAISE UP TO $1.3 BLN - ASAHI
The Asahi said Olympus planned to decide on a tie-up as soon as next month and was looking to raise up to about 100 billion yen ($1.3 billion) in new equity, although it was unclear if either Olympus or its major owners were in talks with any of the short-listed five.
Olympus, responding to the Asahi report, said only that it was considering various reform options and nothing was decided.
Sony, Panasonic and Fujifilm have already been examining the scope and timing of a possible equity stake in Olympus, sources familiar with the matter have said. All three firms are keen on the lucrative medical equipment sector.
Any Olympus-Fujifilm deal, however, would face tough scrutiny from Japan's anti-monopoly watchdog given the two would have a combined market share of more than 80 percent in flexible diagnostic endoscopes, used to look inside patients to check for intestinal cancers and other diseases.
The Asahi report sent shares in Olympus climbing as much as 6 percent, recovering further from the depths of a crisis. The stock closed up 3.25 percent at 1,270 yen, valuing Olympus at around $4.35 billion.
Sony, Fujifilm and Terumo declined comment on Thursday, though Sony boss Howard Stringer had said this week the Olympus situation was still evolving and he could not comment.
"That situation isn't far enough along for me to comment on," he told reporters at the Consumer Electronics Show in Las Vegas.
"We have a relationship with Olympus, have had a relationship because we make components for Olympus. We haven't marched forward in that particular area. It's a little confusing..."
A Panasonic official said on Thursday: "We are not considering a capital tie-up at this point."
Panasonic's comment has failed to extinguish talk in Japan that it might yet take a stake in Olympus, once the disgraced firm has finally put the accounting scandal behind it.
Panasonic President Fumio Ohtsubo, also speaking at the Las Vegas event earlier this week, had said: "The situation is unclear, so we aren't doing anything at this time."
Having recently restated its accounts, Olympus is left highly geared and in need of fresh capital. It remains under investigation by police, prosecutors and regulators.
It is also in the extraordinary position of being run by a board of directors of whom more than half are being sued by Olympus for mismanagement. The current board, however, plans to resign and usher in a new board by March or April.
(Additional reporting by Chikafumi Hodo, Isabel Reynolds and Nathan Layne in TOKYO, and Miyoung Kim and Timothy Kelly in LAS VEGAS; Writing by Mark Bendeich; Editing by Joseph Radford and Ian Geoghegan)
Global Deals Review: 2011 Q3
Global Deals Review: 2011 Q2
Global Deals Review
Consumer Electronics Show
Related Quotes and News
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Back to top
New York Legal
Support & Contact
Advertise With Us
Connect with Reuters
Our Flagship financial information platform incorporating Reuters Insider
An ultra-low latency infrastructure for electronic trading and data distribution
A connected approach to governance, risk and compliance
Our next generation legal research platform
Our global tax workstation
About Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.